Total Valuation
PrimeMD has a market cap or net worth of $1.31M. The enterprise value is $4.56M.
Market Cap$1.31M
Enterprise Value$4.56M
Share Statistics
PrimeMD has 18,698,748 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,698,748
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PrimeMD’s return on equity (ROE) is 0.43 and return on invested capital (ROIC) is 27.54%.
Return on Equity (ROE)0.43
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)27.54%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee10.50M
Profits Per Employee3.14M
Employee Count1
Asset Turnover0.69
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PrimeMD is <0.1. PrimeMD’s PEG ratio is 0.00.
PE Ratio<0.1
PS Ratio0.44
PB Ratio0.63
Price to Fair Value0.63
Price to FCF2.06
Price to Operating Cash Flow<0.01
PEG Ratio0.00
Income Statement
In the last 12 months, PrimeMD had revenue of 10.50M and earned 3.14M in profits. Earnings per share was 0.17.
Revenue10.50M
Gross Profit10.50M
Operating Income4.16M
Pretax Income3.14M
Net Income3.14M
EBITDA3.43M
Earnings Per Share (EPS)0.17
Cash Flow
In the last 12 months, operating cash flow was 3.56M and capital expenditures -772.47K, giving a free cash flow of 2.79M billion.
Operating Cash Flow3.56M
Free Cash Flow2.79M
Free Cash Flow per Share0.15
Dividends & Yields
PrimeMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.85
52-Week Price Change25.71%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
PrimeMD upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
PrimeMD as a current ratio of 16.52, with Debt / Equity ratio of 97.26%
Current Ratio16.52
Quick Ratio16.52
Debt to Market Cap1.54
Net Debt to EBITDA1.33
Interest Coverage Ratio20.62
Taxes
In the past 12 months, PrimeMD has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PrimeMD EV to EBITDA ratio is 2.68, with an EV/FCF ratio of 4.09.
EV to Sales0.87
EV to EBITDA2.68
EV to Free Cash Flow4.09
EV to Operating Cash Flow3.04
Balance Sheet
PrimeMD has $2.59M in cash and marketable securities with $7.13M in debt, giving a net cash position of -$4.54M billion.
Cash & Marketable Securities$2.59M
Total Debt$7.13M
Net Cash-$4.54M
Net Cash Per Share-$0.24
Tangible Book Value Per Share$0.32
Margins
Gross margin is 100.00%, with operating margin of 39.60%, and net profit margin of 29.90%.
Gross Margin100.00%
Operating Margin39.60%
Pretax Margin29.90%
Net Profit Margin29.90%
EBITDA Margin32.63%
EBIT Margin31.82%
Analyst Forecast
The average price target for PrimeMD is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―